Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06373289 · ClinicalTrials.gov registry record · NA
Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm Infants
A NA study, sponsored by University of Alabama at Birmingham.
- Recruiting
- Registry status
- NA
- Development phase
- 39
- Enrollment target
NCT06373289 is a NA study that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 39 participants.
The verdict
NCT06373289, a NA study, is actively recruiting participants, sponsored by University of Alabama at Birmingham.
- RECRUITING
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
Study Summary
Around 50% of infants born extremely preterm develop a chronic lung disease known as bronchopulmonary dysplasia of which some infants will also develop pulmonary hypertension of which 50% of children will die before the age of 2. Physicians are currently limited in their ability to select the most appropriate oxygen targets that will improve outcomes in infants with this condition. This clinical trial will determine whether using different amounts of oxygen improve outcomes in infants with this disease.
Interventions
- DEVICE higher oxygen saturation target using Nellcor pulse oximetry sensors
- DEVICE lower oxygen saturation target using Nellcor pulse oximetry sensors
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2026-07-15 |
| Est. Completion | 2029-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06373289
The ClinicalTrials.gov registry entry for NCT06373289 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which higher oxygen saturation target using Nellcor pulse oximetry sensors is the first listed.
NCT06373289 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06373289 about?
NCT06373289 is a clinical study titled "Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm Infants". Around 50% of infants born extremely preterm develop a chronic lung disease known as bronchopulmonary dysplasia of which some infants will also develop pulmonary hypertension of which 50% of children will die before the age of 2. Physicians are currently limited in their ability to select the most a...
What is the current status of trial NCT06373289?
This trial is currently recruiting. It is a NA study. The enrollment target is 39 participants. The study started on 2026-07-15. Estimated completion is 2029-12-01.
What interventions are being tested in trial NCT06373289?
The interventions under investigation include: higher oxygen saturation target using Nellcor pulse oximetry sensors (DEVICE), lower oxygen saturation target using Nellcor pulse oximetry sensors (DEVICE).
Who is sponsoring clinical trial NCT06373289?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.